Works by Nachbagauer, Raffael


Results: 27
    1
    2
    3
    4

    Pre-existing Antineuraminidase Antibodies Are Associated With Shortened Duration of Influenza A(H1N1)pdm Virus Shedding and Illness in Naturally Infected Adults.

    Published in:
    Clinical Infectious Diseases, 2020, v. 70, n. 11, p. 2290, doi. 10.1093/cid/ciz639
    By:
    • Maier, Hannah E;
    • Nachbagauer, Raffael;
    • Kuan, Guillermina;
    • Ng, Sophia;
    • Lopez, Roger;
    • Sanchez, Nery;
    • Stadlbauer, Daniel;
    • Gresh, Lionel;
    • Schiller, Amy;
    • Rajabhathor, Arvind;
    • Ojeda, Sergio;
    • Guglia, Andrea F;
    • Amanat, Fatima;
    • Balmaseda, Angel;
    • Krammer, Florian;
    • Gordon, Aubree
    Publication type:
    Article
    5

    Safety and Immunogenicity of mRNA-1010, an Investigational Seasonal Influenza Vaccine, in Healthy Adults: Final Results From a Phase 1/2 Randomized Trial.

    Published in:
    Journal of Infectious Diseases, 2025, v. 231, n. 1, p. e113, doi. 10.1093/infdis/jiae329
    By:
    • Ananworanich, Jintanat;
    • Lee, Ivan T;
    • Ensz, David;
    • Carmona, Lizbeth;
    • Schaefers, Kristi;
    • Avanesov, Andrei;
    • Stadlbauer, Daniel;
    • Choi, Angela;
    • Pucci, Alicia;
    • McGrath, Shannon;
    • Kuo, Hsiao-Hsuan;
    • Henry, Carole;
    • Chen, Ren;
    • Huang, Wenmei;
    • Nachbagauer, Raffael;
    • Paris, Robert
    Publication type:
    Article
    6
    7
    8

    Development and Assessment of a Pooled Serum as Candidate Standard to Measure Influenza A Virus Group 1 Hemagglutinin Stalk-Reactive Antibodies.

    Published in:
    Vaccines, 2020, v. 8, n. 4, p. 666, doi. 10.3390/vaccines8040666
    By:
    • Carreño, Juan Manuel;
    • McDonald, Jacqueline U.;
    • Hurst, Tara;
    • Rigsby, Peter;
    • Atkinson, Eleanor;
    • Charles, Lethia;
    • Nachbagauer, Raffael;
    • Behzadi, Mohammad Amin;
    • Strohmeier, Shirin;
    • Coughlan, Lynda;
    • Aydillo, Teresa;
    • Brandenburg, Boerries;
    • García-Sastre, Adolfo;
    • Kaszas, Krisztian;
    • Levine, Min Z.;
    • Manenti, Alessandro;
    • McDermott, Adrian B.;
    • Montomoli, Emanuele;
    • Muchene, Leacky;
    • Narpala, Sandeep R.
    Publication type:
    Article
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18

    Safety and immunogenicity of a phase 1/2 randomized clinical trial of a quadrivalent, mRNA-based seasonal influenza vaccine (mRNA-1010) in healthy adults: interim analysis.

    Published in:
    Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-39376-7
    By:
    • Lee, Ivan T.;
    • Nachbagauer, Raffael;
    • Ensz, David;
    • Schwartz, Howard;
    • Carmona, Lizbeth;
    • Schaefers, Kristi;
    • Avanesov, Andrei;
    • Stadlbauer, Daniel;
    • Henry, Carole;
    • Chen, Ren;
    • Huang, Wenmei;
    • Schrempp, Daniela Ramirez;
    • Ananworanich, Jintanat;
    • Paris, Robert
    Publication type:
    Article
    19

    Progress in vaccine development for infectious diseases—a Keystone Symposia report.

    Published in:
    Annals of the New York Academy of Sciences, 2023, v. 1524, n. 1, p. 65, doi. 10.1111/nyas.14975
    By:
    • Cable, Jennifer;
    • Graham, Barney S.;
    • Koup, Richard A.;
    • Seder, Robert A.;
    • Karikó, Katalin;
    • Pardi, Norbert;
    • Barouch, Dan H.;
    • Sharma, Bhawna;
    • Rauch, Susanne;
    • Nachbagauer, Raffael;
    • Forsell, Mattias N. E.;
    • Schotsaert, Michael;
    • Ellebedy, Ali H.;
    • Loré, Karin;
    • Irvine, Darrell J.;
    • Pilkington, Emily;
    • Tahtinen, Siri;
    • Thompson, Elizabeth A.;
    • Feraoun, Yanis;
    • King, Neil P.
    Publication type:
    Article
    20
    21
    22

    Pandemic influenza virus vaccines boost hemagglutinin stalk-specific antibody responses in primed adult and pediatric cohorts.

    Published in:
    NPJ Vaccines, 2019, v. 4, n. 1, p. N.PAG, doi. 10.1038/s41541-019-0147-z
    By:
    • Nachbagauer, Raffael;
    • Salaun, Bruno;
    • Stadlbauer, Daniel;
    • Behzadi, Mohammad A.;
    • Friel, Damien;
    • Rajabhathor, Arvind;
    • Choi, Angela;
    • Albrecht, Randy A.;
    • Debois, Muriel;
    • García-Sastre, Adolfo;
    • Rouxel, Ronan N.;
    • Sun, Weina;
    • Palese, Peter;
    • Mallett, Corey P.;
    • Innis, Bruce L.;
    • Krammer, Florian;
    • Claeys, Carine
    Publication type:
    Article
    23
    24
    25
    26
    27

    First exposure to the pandemic H1N1 virus induced broadly neutralizing antibodies targeting hemagglutinin head epitopes.

    Published in:
    Science Translational Medicine, 2021, v. 13, n. 596, p. 1, doi. 10.1126/scitranslmed.abg4535
    By:
    • Guthmiller, Jenna J.;
    • Han, Julianna;
    • Li, Lei;
    • Freyn, Alec W.;
    • Liu, Sean T. H.;
    • Stovicek, Olivia;
    • Stamper, Christopher T.;
    • Dugan, Haley L.;
    • Tepora, Micah E.;
    • Utset, Henry A.;
    • Bitar, Dalia J.;
    • Hamel, Natalie J.;
    • Changrob, Siriruk;
    • Zheng, Nai-Ying;
    • Huang, Min;
    • Krammer, Florian;
    • Nachbagauer, Raffael;
    • Palese, Peter;
    • Ward, Andrew B.;
    • Wilson, Patrick C.
    Publication type:
    Article